UP - logo
E-resources
Peer reviewed Open access
  • Introduction of SARS in Fra...
    Desenclos, Jean-Claude; van der Werf, Sylvie; Bonmarin, Isabelle; Levy-Bruhl, Daniel; Yazdanpanah, Yazdan; Hoen, Bruno; Emmanuelli, Julien; Lesens, Olivier; Dupon, Michel; Natali, François; Michelet, Christian; Reynes, Jacques; Guery, Benoit; Larsen, Christine; Semaille, Caroline; Mouton, Daniel; André, Michel; Escriou, Nicolas; Burguière, Anna; Manuguerra, Jean-Claude; Coignard, Bruno; Lepoutre, Agnés; Meffre, Christine; Bitar, Dounia; Decludt, Bénédicte; Capek, Isabelle; Antona, Denise; Che, Didier; Herida, Magid; Infuso, Andréa; Sauri, Christine; Brücker, Gilles; Hubert, Bruno; LeGoff, Dominique; Scheidegger, Suzanne

    Emerging infectious diseases, 02/2004, Volume: 10, Issue: 2
    Journal Article

    We describe severe acute respiratory syndrome (SARS) in France. Patients meeting the World Health Organization definition of a suspected case underwent a clinical, radiologic, and biologic assessment at the closest university-affiliated infectious disease ward. Suspected cases were immediately reported to the Institut de Veille Sanitaire. Probable case-patients were isolated, their contacts quarantined at home, and were followed for 10 days after exposure. Five probable cases occurred from March through April 2003; four were confirmed as SARS coronavirus by reverse transcription-polymerase chain reaction, serologic testing, or both. The index case-patient (patient A), who had worked in the French hospital of Hanoi, Vietnam, was the most probable source of transmission for the three other confirmed cases; two had been exposed to patient A while on the Hanoi-Paris flight of March 22-23. Timely detection, isolation of probable case-patients, and quarantine of their contacts appear to have been effective in preventing the secondary spread of SARS in France.